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Abstract
Despite a close association between adiponectin and both hypertension and type 2 diabetes,
the relationship between adiponectin and metabolic syndrome has not yet been well-investigated.
To examine and evaluate the association between serum adiponectin levels and metabolic syn-
drome based on Japanese diagnostic criteria, we analyzed adiponectin and anthropometric parame-
ters in 869 male employees aged 40-59 who belonged to a health insurance society in Fukuoka Pre-
fecture and who underwent annual health check-ups from August 2006 to July 2007. Two hundred
and thirty-two of the 869 subjects (26.7%) were diagnosed with metabolic syndrome. The serum
adiponectin levels were significantly higher in the non-metabolic syndrome group. In a multiple
logistic regression analysis, the subjects in the top quartile of serum adiponectin (adjusted odds
ratio:0.36;95% confidence interval:0.21-0.63) and the second (adjusted odds ratio:0.51;95% con-
fidence interval:0.31-0.84) quartile had a significantly decreased risk for metabolic syndrome in
comparison to the bottom quartile. The dose-response relationship between serum adiponectin lev-
els and metabolic syndrome was significant (p for trend 0.0001) after adjusting for age, body mass
index, smoking status, and drinking status. The current findings suggest that hypoadiponectinemia
is inversely correlated with the risk of metabolic syndrome in middle-aged Japanese male workers.
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Despite a close association between adiponectin and both hypertension and type 2 diabetes,  the rela-
tionship between adiponectin and metabolic syndrome has not yet been well-investigated.  To examine 
and evaluate the association between serum adiponectin levels and metabolic syndrome based on 
Japanese diagnostic criteria,  we analyzed adiponectin and anthropometric parameters in 869 male 
employees aged 40-59 who belonged to a health insurance society in Fukuoka Prefecture and who 
underwent annual health check-ups from August 2006 to July 2007.  Two hundred and thirty-two of the 
869 subjects (26.7ｵ) were diagnosed with metabolic syndrome.  The serum adiponectin levels were 
signiﬁcantly higher in the non-metabolic syndrome group.  In a multiple logistic regression analysis,  
the subjects in the top quartile of serum adiponectin (adjusted odds ratio: 0.36; 95ｵ conﬁdence inter-
val: 0.21-0.63) and the second (adjusted odds ratio: 0.51; 95ｵ conﬁdence interval: 0.31-0.84) quartile 
had a signiﬁcantly decreased risk for metabolic syndrome in comparison to the bottom quartile.  The 
dose-response relationship between serum adiponectin levels and metabolic syndrome was signiﬁcant (p 
for trend ＜0.0001) after adjusting for age,  body mass index,  smoking status,  and drinking status.  The 
current ﬁndings suggest that hypoadiponectinemia is inversely correlated with the risk of metabolic 
syndrome in middle-aged Japanese male workers.
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he following factors,  which cluster in individ-
uals,  are associated with an increased risk of 
developing diseases of the circulatory system: high 
blood pressure,  low levels of high-density lipoprotein 
(HDL) cholesterol,  high triglyceride levels,  high 
plasma glucose concentrations,  and obesity.  These 
associated risk factors have together been called 
metabolic syndrome [1-3].
　 The mechanisms underlying metabolic syndrome are 
still not fully known; however,  recent studies have 
proposed an association between adipocyte-derived 
hormone and hypertension [4,  5],  type 2 diabetes 
mellitus [6,  7],  and dyslipidemia [8].  Adiponectin is 
a hormone that is speciﬁcally secreted by adipocytes 
and that acts as an antidiabetic and antiatherogenic 
adipocytokine [3,  9,  10].  Adiponectin exhibits vari-
ous antiatherogenic eﬀects on vascular cells,  thereby 
suppressing the expression of adhesion molecules in 
vascular endothelial cells,  the proliferation of smooth 
muscle cells,  and cholesteryl-ester accumulation in 
T
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macrophages [10,  11].
　 Visceral fat accumulation is more strongly related 
to the induction of metabolic syndrome than subcuta-
neous fat accumulation [3].  Although both visceral fat 
and subcutaneous fat secrete peptides associated with 
insulin action in several systems,  it appears that vis-
ceral fat and subcutaneous fat are biologically distinct 
because the gene expression of visceral and sub-
cutaneous fat deposits tends to diﬀer in young rats 
[12].  In addition,  adiponectin expression is signiﬁ-
cantly lower in the visceral adipose tissue of geneti-
cally obese rats than in lean rats,  but no diﬀerences 
have been observed when the subcutaneous adipose 
tissue specimens of the same animals are compared 
[13].
　 Serum adiponectin levels may therefore be a useful 
marker of visceral fat accumulation.  However,  few 
studies have attempted to determine precise relation-
ships between adiponectin levels and the risk of meta-
bolic syndrome in humans [14,  15].  In this context,  
the main aim of the present study was to examine and 
evaluate the association between serum adiponectin 
levels and metabolic syndrome.
Subjects and Methods
　 Subjects. The study subjects were recruited 
from male employees aged 40-59 who belonged to a 
health insurance society in Fukuoka Prefecture,  
Japan.  From August 2006 to July 2007,  we invited 
1,430 male employees aged 40-59 who underwent 
annual health check-ups to participate in this study.  
Forty-seven (3.3ｵ) did not agree to participate,  and 
blood samples and a questionnaire were thus obtained 
from 1,383 participants.
　 A questionnaire was used to obtain information on 
the subjectsʼ smoking status and alcohol consumption.  
The systolic blood pressure (SBP) and diastolic blood 
pressure (DBP) were measured once using a standard 
mercury sphygmomanometer with the cuﬀ on the right 
arm and the subjects in a sitting position.  The waist 
circumference at the umbilical level was measured in 
the late exhalation phase when the subjects were in a 
standing position.
　 The serum adiponectin levels were measured by a 
solid phase enzyme linked immunosorbent assay 
(ELISA) using a commercially available kit (adipo-
nectin ELISA kit; Otsuka Pharmaceutical Co.  Ltd.,  
Tokushima,  Japan).  The serum total cholesterol (TC) 
and low-density lipoprotein cholesterol (LDL) levels 
were measured enzymatically using commercial enzyme 
kits (Wako (Osaka,  Japan) and Daiichi Kagaku 
(Tokyo,  Japan),  respectively).  The high density lipo-
protein cholesterol (HDL) was measured using the 
direct method.
　 The study protocol was approved by the Ethics 
Committee of Fukuoka University,  and written 
informed consent was obtained from all participants.
　 Deﬁnition of metabolic syndrome. We 
deﬁned metabolic syndrome based on the Japanese 
diagnostic criteria [2].  In addition to waist circum-
ference (ｧ85cm in men),  the presence of at least 2 of 
the following 3 abnormalities indicated metabolic 
syndrome:
1) Dyslipidemia: triglyceridesｧ1.7mmol/l and/or HDL 
cholesterol＜1.0mmol/l.
2) High blood pressure: systolic blood pressureｧ
130mm Hg and/or diastolic blood pressureｧ85mm 
Hg.
3) Hyperglycemia: fasting plasma glucoseｧ6.1mmol/l.
　 Statistics. We excluded 510 participants 
because they had fasted for less than 8h.  For the 
statistical analysis,  an additional 4 participants with 
missing data were excluded.  Finally,  869 subjects 
were selected for the study.  The subject characteris-
tics are presented as n (ｵ),  and the means and stan-
dard deviations.  The Studentʼs t-test was used to 
compare the various parameters between the metabolic 
syndrome group and the non-metabolic syndrome 
group.  The χ2 test was used for categorical data.  A 
logistic regression analysis was used to assess the risk 
of metabolic syndrome in the quartiles of serum adi-
ponectin.  For comparative purposes,  the odds ratios 
were calculated by a crude analysis and with adjust-
ments for age (by one year),  body mass index (by １
kg/m2),  smoking status (non-smokers,  ex-smokers,  
current-smokers),  drinking status (non-drinkers,  
occasional drinkers,  regular drinkers).  The results 
are presented as the odds ratios (OR) together with 
their 95ｵ conﬁdence intervals (95ｵ CI).  A two-sided 
p value of ＜0.05 was considered to be statistically 
signiﬁcant.  All analyses were performed using the 
Statistical Analysis System Version 9.1 (SAS Insti-
tute,  Cary,  NC,  USA).
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Results
　 The subject characteristics are shown in Table 1.  
In this study,  the serum adiponectin levels were 
divided into quartiles.  The quartile cutoﬀ points 
were 4.5,  6.3,  and 8.5µg/ml.  Two hundred and 
thirty-two subjects (26.7ｵ) were thus diagnosed as 
having metabolic syndrome.  No signiﬁcant diﬀerences 
in age,  smoking,  drinking habit,  and serum LDL cho-
lesterol levels between the metabolic syndrome and 
non-metabolic syndrome subjects were observed.  A 
signiﬁcant diﬀerence was observed in the waist cir-
cumference,  SBP,  DBP,  fasting plasma glucose,  
serum total cholesterol,  HDL,  serum triglyceride,  
and serum adiponectin levels between the metabolic 
syndrome and non-metabolic syndrome subjects.
　 The subjects with metabolic syndrome had lower 
serum adiponectin levels than those without metabolic 
syndrome.  The proportion of subjects with serum 
adiponectin levels below 4.7 (µg/ml) in the metabolic 
syndrome group and non-metabolic syndrome group 
were 41.4ｵ (96/232) and 20.4ｵ (130/637),  respec-
tively.  The average of serum adiponectin was clearly 
larger in the non-metabolic syndrome group than in the 
metabolic syndrome group.  The proportion of subjects 
decreased as serum adiponectin levels rose in the 
metabolic syndrome group,  but the proportion con-
versely increased as serum adiponectin levels rose in 
the non-metabolic syndrome group.
　 Next,  we carried out a logistic regression analysis 
to assess the associations between metabolic syndrome 
and potential risk factors.  As shown in Table 2,  the 
subjects in the top (crude OR: 0.19; 95ｵ CI: 0.12-
0.31),  third (crude OR: 0.34; 95ｵ CI: 0.22-0.52),  
and second (crude OR: 0.61; 95ｵ CI: 0.41-0.91) 
quartiles had a signiﬁcantly decreased risk for meta-
bolic syndrome in comparison to the bottom quartile 
based on a logistic regression analysis.
　 The dose-response relationship between serum 
adiponectin levels and metabolic syndrome was signiﬁ-
cant (p for trend ＜0.0001) for both a univariate and a 
multivariate analysis.  However,  adjusting for poten-
327Adiponectin and Metabolic SyndromeDecember 2009
Table 1　 Characteristics of the subjects
Metabolic syndrome
p-value(＋) (－)
Number of subjects 232 637
Age (years) 49.2±5.1 49.7±5.5 0.230
BMI (kg/m2) 26.8±2.9 23.2±2.9 p＜0.001
Waist circumference (cm) 93.4±6.7 84.2±7.6 p＜0.001
Systolic blood pressure (mmHg) 147.3±19.2 129.9±17.4 p＜0.001
Diastolic blood pressure (mmHg)  91.4±12.4  80.6±12.1 p＜0.001
Fasting plasma glucose (mmol/l)  6.3±1.9  5.4±1.2 p＜0.001
Serum total cholesterol (mmol/l)  5.6±0.9  5.3±0.9 p＜0.001
Serum HDL cholesterol (mmol/l)  1.3±0.3  1.5±0.3 p＜0.001
Serum LDL cholesterol (mmol/l)  3.2±0.8  3.1±0.8 0.091
Serum triglyceride (mmol/l)  2.5±1.5  1.4±0.9 p＜0.001
Serum adiponectin (µg/ml)
　Average  5.6±2.3  7.3±3.5 p＜0.001
　＜4.7  96 (41.4%) 130 (20.4%) p＜0.001
　4.7-6.3  66 (28.4%) 146 (22.9%)
　6.2-8.5  43 (18.5%) 172 (27.0%)
　＞8.5  27 (11.6%) 189 (29.7%)
Smoking status
　Non-smokers  50 (50.9%) 159 (53.1%) 0.196
　Ex-smokers  64 (27.6%) 140 (22.0%)
　Current-smokers 118 (21.6%) 338 (25.0%)
Drinking status
　Non-drinkers 130 (56.0%) 350 (54.9%) 0.558
　Occasional drinkers  64 (27.6%) 163 (25.6%)
　Regular drinkers  38 (16.4%) 124 (19.5%)
Data are the means ± SD.  BMI,  body mass index.
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tial confounding factors attenuated the dose-response 
relationship between serum adiponectin levels and 
metabolic syndrome.  The logistic regression analysis 
showed the serum adiponectin levels to demonstrate an 
inverse correlation with the risk of metabolic syn-
drome.
Discussion
　 This study assessed the association between serum 
adiponectin levels and metabolic syndrome according 
to a deﬁnition based on Japanese diagnostic criteria 
[2].  BMI was positively associated with the risk of 
metabolic syndrome,  and the risk of metabolic syn-
drome for subjects with lower serum adiponectin lev-
els was signiﬁcantly high after adjusting for the BMI.  
BMI is an important confounding factor when evaluat-
ing the association between serum adiponectin levels 
and metabolic syndrome because the BMI has been 
reported to inversely correlate with adiponectin levels 
[10,  16].  In this study,  the deﬁnition of metabolic 
syndrome includes waist circumference but no BMI.  
The present results show low serum adiponectin levels 
to be associated with metabolic syndrome after adjust-
ing for the BMI.
　 The odds ratios for both smoking and drinking 
status were not signiﬁcantly correlated with metabolic 
syndrome in this study.  The association between cur-
rent smoking and metabolic syndrome is confounded by 
certain factors that increase the circulating white 
blood cell count in Japanese women,  as in men.  [17,  
18] Smoking is a potential confounding factor for the 
association between adiponectin and metabolic syn-
drome because plasma adiponectin levels are signiﬁ-
cantly lower in current smokers than in never-smok-
ers [19].
　 The relationship between drinking habits and meta-
bolic syndrome remains controversial.  While a posi-
tive association [20] and no signiﬁcant association 
[21] have been reported,  a lower prevalence of meta-
bolic syndrome is associated with mild to moderate 
alcohol consumption [22-25].  In addition,  smoking 
has been reported to decrease [19],  while moderate 
alcohol consumption has been reported to increase the 
circulating adiponectin concentrations [7,  25].  Smok-
ing and drinking are confounding factors regarding the 
relationship between adiponectin levels and metabolic 
syndrome.
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Table 2　 Crude and adjusted odds ratios for metabolic syndrome based on the adiponectin level quartiles
Variables
Crude Adjusteda
OR 95% CI OR 95% CI
Serum adiponectin level (µg/mL)
　＜4.7 (reference) (reference)
　4.7-6.3 0.61 (0.41-0.91) 0.78 (0.49-1.24)
　6.2-8.5 0.34 (0.22-0.52) 0.51 (0.31-0.84)
　＞8.5 0.19 (0.12-0.31) 0.36 (0.21-0.63)
p for trend＜0.0001 p for trend＜0.0001
Age (by one year) 0.98 (0.96-1.01) 1.03 (0.99-1.06)
Body mass index (by１kg/m2) 1.54 (1.44-1.66) 1.53 (1.43-1.65)
Smoking status
　Non-smokers (reference) (reference)
　Ex-smokers 1.45 (0.94-2.24) 1.46 (0.87-2.44)
　Current-smokers 1.11 (0.76-1.62) 1.39 (0.88-2.19)
Drinking status
　Non-drinkers (reference) (reference)
　Occasional drinkers 1.33 (0.84-2.10) 1.61 (0.87-2.44)
　Regular drinkers 1.28 (0.85-1.93) 1.94 (0.88-2.19)
OR,  Odds Ratio; CI,  conﬁdence interval.  aAdjusted for age,  body mass index,  smoking status,  drinking status.
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　 These results demonstrate that serum adiponectin 
levels are signiﬁcantly lower in subjects with meta-
bolic syndrome than in those without metabolic syn-
drome based on a univariate analysis.  Moreover,  in a 
logistic regression analysis,  the subjects in the lowest 
quartile had a ﬁvefold greater risk of metabolic syn-
drome than those in the highest quartile.  Even after 
adjusting for potential confounding factors,  this asso-
ciation remained signiﬁcant.  In addition,  the dose-
response relationship between the risk of metabolic 
syndrome and the serum adiponectin levels was sig-
niﬁcant.
　 An association between adiponectin and hyperten-
sion [4],  type 2 diabetes mellitus [6,  7],  and dys-
lipidemia [8] has been reported.  Our data are consis-
tent with the ﬁndings of the above-mentioned study and 
also indicate that adiponectin plays an important role 
in metabolic syndrome.  Adiponectin exhibits various 
antiatherogenic eﬀects on vascular cells,  thereby sup-
pressing the expression of adhesion molecules in vas-
cular endothelial cells,  the proliferation of smooth 
muscle cells,  and cholesteryl-ester accumulation in 
macrophages [10,  11].  However,  details regarding 
the mechanisms underlying the inverse association 
between adiponectin and metabolic syndrome are not 
yet clear and remain to be elucidated.
　 This study has certain limitations.  First,  it was a 
cross-sectional study.  Decreased secretion of adipo-
nectin occurs earlier than metabolic syndrome because 
adiponectin levels are positively correlated with the 
insulin sensitivity [24] and an inverse relationship 
between serum adiponectin levels and insulin resis-
tance [7] has been reported.  However,  the serum 
adiponectin concentrations do not show any correla-
tions with the homeostasis model assessment index for 
either non-obese or obese normoglycemic subjects 
[26].  We cannot rule out the probability that the 
presence of metabolic syndrome decreases the secre-
tion of adiponectin.  Therefore,  the temporality of 
such a causal relationship cannot be inferred.  A pro-
spective study with a larger sample size is thus 
required to clarify this issue.
　 Next,  the subjects of this study were middle-aged 
Japanese male workers.  Most of the subjects of stud-
ies regarding the relationship between adiponectin 
levels and hypertension [4],  type 2 diabetes mellitus 
[6,  7] and dyslipidemia [8],  and life style factors 
[16] have been male.  A few studies have also ana-
lyzed the relationships between adiponectin levels and 
the risk of metabolic syndrome for women [14,  24].  
However,  the number of subjects evaluated in these 
studies has not been large.  As such,  further study is 
necessary to determine whether or not the results of 
this study can be applied to females.
　 In conclusion,  we have shown herein that in mid-
dle-aged Japanese male workers,  adiponectin levels are 
inversely correlated with the risk of metabolic syn-
drome after adjusting for potential confounding fac-
tors.  Clarifying whether adiponectin may have a pre-
dictive value in the natural course of metabolic 
syndrome and whether lifestyle factors may alter the 
risk of metabolic syndrome awaits further investiga-
tion.
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